0000950170-25-009791.txt : 20250128 0000950170-25-009791.hdr.sgml : 20250128 20250128160510 ACCESSION NUMBER: 0000950170-25-009791 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250125 FILED AS OF DATE: 20250128 DATE AS OF CHANGE: 20250128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sermon Charles CENTRAL INDEX KEY: 0001687318 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38452 FILM NUMBER: 25564120 MAIL ADDRESS: STREET 1: C/O ALBIREO PHARMA INC. STREET 2: 50 MILK ST. 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mereo BioPharma Group plc CENTRAL INDEX KEY: 0001719714 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE CAVENDISH PLACE STREET 2: FOURTH FLOOR CITY: LONDON STATE: X0 ZIP: W1G0QF BUSINESS PHONE: 4403330237300 MAIL ADDRESS: STREET 1: ONE CAVENDISH PLACE STREET 2: FOURTH FLOOR CITY: LONDON STATE: X0 ZIP: W1G0QF FORMER COMPANY: FORMER CONFORMED NAME: Mereo Biopharma Group plc DATE OF NAME CHANGE: 20171016 4 1 ownership.xml 4 X0508 4 2025-01-25 0001719714 Mereo BioPharma Group plc MREO 0001687318 Sermon Charles C/O MEREO BIOPHARMA GROUP PLC 4TH FLOOR, ONE CAVENDISH PLACE LONDON X0 W1G 0QF UNITED KINGDOM false true false false General Counsel false Share Options (Right to buy) 2.91 2025-01-25 4 A false 262000 0 A 2035-01-25 American Depository Shares 262000 262000 D 25% of the shares underlying this share option will vest and become exercisable on January 25, 2026, with the remainder vesting in equal monthly installments for the three years thereafter. Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. /s/ Christine Fox, by power of attorney 2025-01-28